Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled National Notifiable Diseases Surveillance System. The purpose of this data collection is to provide the official source of statistics in the United States for nationally notifiable conditions.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 220 (Wednesday, November 16, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 220 (Wednesday, November 16, 2022)]
[Notices]
[Pages 68699-68701]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-24921]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-23-0728; Docket No. CDC-2022-0130]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on a continuing information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled National Notifiable Diseases Surveillance System. The purpose of
this data collection is to provide the official source of statistics in
the United States for nationally notifiable conditions.
DATES: CDC must receive written comments on or before January 17, 2023.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0130 by either of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">www.regulations.gov</a>. Follow
the instructions for submitting comments.
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://www.regulations.gov">www.regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (<a href="http://www.regulations.gov">www.regulations.gov</a>) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: <a href="/cdn-cgi/l/email-protection#d1bebcb391b2b5b2ffb6bea7"><span class="__cf_email__" data-cfemail="6807050a280b0c0b460f071e">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who
[[Page 68700]]
are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
National Notifiable Diseases Surveillance System (NNDSS) (OMB
Control No. 0920-0728, Exp. 7/31/2025)--Revision--Center for
Surveillance, Epidemiology and Laboratory Services (CSELS), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The Public Health Services Act (42 U.S.C. 241) authorizes CDC to
disseminate nationally notifiable condition information. The National
Notifiable Diseases Surveillance System (NNDSS) is based on data
collected at the state, territorial and local levels because of
legislation and regulations in those jurisdictions that require health
care providers, medical laboratories, and other entities to submit
health-related data on reportable conditions to public health
departments. These reportable conditions, which include infectious and
non-infectious diseases, vary by jurisdiction depending upon each
jurisdiction's health priorities and needs. Each year, the Council of
State and Territorial Epidemiologists (CSTE), supported by CDC,
determines which reportable conditions should be designated nationally
notifiable or under standardized surveillance.
CDC requests a three-year approval for a Revision for the NNDSS
(OMB Control No. 0920-0728, Exp. 07/31/2025). This Revision includes
requests for approval to: (1) receive case notification data for
Carbapenemase-Producing Organisms, a new notifiable condition (NC); (2)
receive case notification data for Strongyloidiasis, a new condition
under standardized surveillance (CSS); and (3) receive new disease-
specific data elements for Carbapenemase-Producing Organisms, Candida
auris, Melioidosis, Leptospirosis, Brucellosis, Carbon Monoxide
Poisoning, and Hepatitis.
The NNDSS currently facilitates the submission and aggregation of
case notification data voluntarily submitted to CDC from 60
jurisdictions: public health departments in every U.S. state, New York
City, Washington, DC, five U.S. territories (American Samoa, the
Commonwealth of Northern Mariana Islands, Guam, Puerto Rico, and the
U.S. Virgin Islands), and three freely associated states (Federated
States of Micronesia, the Republic of the Marshall Islands, and the
Republic of Palau). This information is shared across jurisdictional
boundaries and both surveillance and prevention and control activities
are coordinated at regional and national levels.
Approximately 90% of case notifications are encrypted and submitted
to NNDSS electronically from already existing databases by automated
electronic messages. When automated transmission is not possible, case
notifications are faxed, emailed, uploaded to a secure network or
entered into a secure website. All case notifications that are faxed or
emailed are done so in the form of an aggregate weekly or annual
report, not individual cases. These different mechanisms used to send
case notifications to CDC vary by the jurisdiction and the disease or
condition. Jurisdictions remove most personally identifiable
information (PII) before data are submitted to CDC, but some data
elements (e.g., date of birth, date of diagnosis, county of residence)
could potentially be combined with other information to identify
individuals. Private information is not disclosed unless otherwise
compelled by law. All data are treated in a secure manner consistent
with the technical, administrative, and operational controls required
by the Federal Information Security Management Act of 2002 (FISMA) and
the 2010 National Institute of Standards and Technology (NIST)
Recommended Security Controls for Federal Information Systems and
Organizations. Weekly tables of nationally notifiable diseases are
available through CDC WONDER and <a href="http://data.cdc.gov">data.cdc.gov</a>. Annual summaries of
finalized nationally notifiable disease data are published on CDC
WONDER and <a href="http://data.cdc.gov">data.cdc.gov</a> and disease-specific data are published by
individual CDC programs.
The burden estimates include the number of hours that the public
health department uses to process and send case notification data from
their jurisdiction to CDC. Specifically, the burden estimates include
separate burden hours incurred for automated and non-automated
transmissions, separate weekly burden hours incurred for modernizing
surveillance systems as part of CDC's Data Modernization Initiative
(DMI) implementation, separate burden hours incurred for annual data
reconciliation and submission, and separate one-time burden hours
incurred for the addition of new diseases and data elements. The burden
estimates for the one-time burden for reporting jurisdictions are for
the addition of case notification data for Carbapenemase-Producing
Organisms, a new notifiable condition (NC); Strongyloidiasis, a new
condition under standardized surveillance (CSS); and receive new
disease-specific data elements for Carbapenemase-Producing Organisms,
Candida auris, Melioidosis, Leptospirosis, Brucellosis, Carbon Monoxide
Poisoning, and Hepatitis.
The estimated annual burden for the 257 respondents is 18,354
hours, and has increased slightly from 18,294 to 18,354 due to the
additional disease-specific data elements added in this Revision. There
are no costs to respondents other than their time to participate.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
States........................ Weekly 50 52 20/60 867
(Automated).
States........................ Weekly (Non- 10 52 2 1,040
automated).
States........................ Weekly (DMI 50 52 4 10,400
Implementation).
States........................ Annual.......... 50 1 75 3,750
States........................ One-time 50 1 2 100
Addition of
Diseases and
Data Elements.
Territories................... Weekly 5 52 20/60 87
(Automated).
Territories................... Weekly, 5 56 20/60 93
Quarterly (Non-
automated).
Territories................... Weekly (DMI 5 52 4 1,040
Implementation).
Territories................... Annual.......... 5 1 5 25
[[Page 68701]]
Territories................... One-time 5 1 2 10
Addition of
Diseases and
Data Elements.
Freely Associated States...... Weekly 3 52 20/60 52
(Automated).
Freely Associated States...... Weekly, 3 56 20/60 56
Quarterly (Non-
automated).
Freely Associated States...... Annual.......... 3 1 5 15
Freely Associated States...... One-time 3 1 2 6
Addition of
Diseases and
Data Elements.
Cities........................ Weekly 2 52 20/60 35
(Automated).
Cities........................ Weekly (Non- 2 52 2 208
automated).
Cities........................ Weekly (DMI 2 52 4 416
Implementation).
Cities........................ Annual.......... 2 1 75 150
Cities........................ One-time 2 1 2 4
Addition of
Diseases and
Data Elements.
---------------------------------------------------------------
Total..................... ................ .............. .............. .............. 18,354
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2022-24921 Filed 11-15-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.